These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1818791)

  • 1. Advanced nonenzymatic glycation endproducts (AGE): their relevance to aging and the pathogenesis of late diabetic complications.
    Sensi M; Pricci F; Andreani D; Di Mario U
    Diabetes Res; 1991 Jan; 16(1):1-9. PubMed ID: 1818791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Aging mechanisms of proteins].
    Gillery P; Monboisse JC; Maquart FX; Borel JP
    Diabete Metab; 1991; 17(1):1-16. PubMed ID: 1651260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of non-enzymic glycation of proteins by dietary agents: prospects for alleviating diabetic complications.
    Saraswat M; Reddy PY; Muthenna P; Reddy GB
    Br J Nutr; 2009 Jun; 101(11):1714-21. PubMed ID: 18986599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of glycation process on the macromolecular structure of the glomerular basement membranes and on the glomerular functions in aging and diabetes mellitus].
    Sternberg M; Urios P; Grigorova-Borsos AM
    C R Seances Soc Biol Fil; 1995; 189(6):967-85. PubMed ID: 8763028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced glycation endproducts: what is their relevance to diabetic complications?
    Ahmed N; Thornalley PJ
    Diabetes Obes Metab; 2007 May; 9(3):233-45. PubMed ID: 17391149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An agent cleaving glucose-derived protein crosslinks in vitro and in vivo.
    Vasan S; Zhang X; Zhang X; Kapurniotu A; Bernhagen J; Teichberg S; Basgen J; Wagle D; Shih D; Terlecky I; Bucala R; Cerami A; Egan J; Ulrich P
    Nature; 1996 Jul; 382(6588):275-8. PubMed ID: 8717046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end products in vitreous: Structural and functional implications for diabetic vitreopathy.
    Stitt AW; Moore JE; Sharkey JA; Murphy G; Simpson DA; Bucala R; Vlassara H; Archer DB
    Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2517-23. PubMed ID: 9856760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in vitro approach to the chronological aging of skin by glycation of the collagen: the biological effect of glycation on the reconstructed skin model.
    Pageon H; Asselineau D
    Ann N Y Acad Sci; 2005 Jun; 1043():529-32. PubMed ID: 16037275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry.
    Thornalley PJ; Battah S; Ahmed N; Karachalias N; Agalou S; Babaei-Jadidi R; Dawnay A
    Biochem J; 2003 Nov; 375(Pt 3):581-92. PubMed ID: 12885296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathological implications of protein glycation.
    Brownlee M
    Clin Invest Med; 1995 Aug; 18(4):275-81. PubMed ID: 8549013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel inhibitors of advanced glycation endproducts (part II).
    Rahbar S; Yerneni KK; Scott S; Gonzales N; Lalezari I
    Mol Cell Biol Res Commun; 2000 Jun; 3(6):360-6. PubMed ID: 11032758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunochemical crossreactivity of antibodies specific for "advanced glycation endproducts" with "advanced lipoxidation endproducts".
    Richter T; Münch G; Lüth HJ; Arendt T; Kientsch-Engel R; Stahl P; Fengler D; Kuhla B
    Neurobiol Aging; 2005 Apr; 26(4):465-74. PubMed ID: 15653175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of the Maillard reaction on the physical properties and cell interactions of collagen.
    Avery NC; Bailey AJ
    Pathol Biol (Paris); 2006 Sep; 54(7):387-95. PubMed ID: 16962252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nonenzymatic glycation of proteins and nucleic acids, their importance for the development of diabetic complications, possible molecular basis of aging and autoimmunological processes.
    Krantz S; Lober M; Henschel L
    Exp Clin Endocrinol; 1986 Dec; 88(3):257-69. PubMed ID: 3549330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibition of sugar-induced structural alterations in collagen by aspirin and other compounds.
    Malik NS; Meek KM
    Biochem Biophys Res Commun; 1994 Mar; 199(2):683-6. PubMed ID: 8135810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonenzymatic glycosylation (glycation) of lens crystallins in diabetes and aging.
    Abraham EC; Swamy MS; Perry RE
    Prog Clin Biol Res; 1989; 304():123-39. PubMed ID: 2780679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advanced glycosylation in diabetes mellitus. Occurrence of late complications].
    Esteves MC; Gonçalves AM; Caldeira JL
    Acta Med Port; 2001; 14(4):409-12. PubMed ID: 11762182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-linking of the extracellular matrix by the maillard reaction in aging and diabetes: an update on "a puzzle nearing resolution".
    Monnier VM; Mustata GT; Biemel KL; Reihl O; Lederer MO; Zhenyu D; Sell DR
    Ann N Y Acad Sci; 2005 Jun; 1043():533-44. PubMed ID: 16037276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonenzymatic glycosylation of erythrocyte membrane proteins. Relevance to diabetes.
    Miller JA; Gravallese E; Bunn HF
    J Clin Invest; 1980 Apr; 65(4):896-901. PubMed ID: 7358849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics, formation, and pathophysiology of glucosepane: a major protein cross-link.
    Sjöberg JS; Bulterijs S
    Rejuvenation Res; 2009 Apr; 12(2):137-48. PubMed ID: 19415980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.